<SEC-DOCUMENT>0001477932-22-005336.txt : 20220725
<SEC-HEADER>0001477932-22-005336.hdr.sgml : 20220725
<ACCEPTANCE-DATETIME>20220725060247
ACCESSION NUMBER:		0001477932-22-005336
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20220719
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220725
DATE AS OF CHANGE:		20220725

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cosmos Holdings Inc.
		CENTRAL INDEX KEY:			0001474167
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				270611758
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41308
		FILM NUMBER:		221100930

	BUSINESS ADDRESS:	
		STREET 1:		141 W. JACKSON BLVD
		STREET 2:		SUITE 4236
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60604
		BUSINESS PHONE:		312-536-3102

	MAIL ADDRESS:	
		STREET 1:		141 W. JACKSON BLVD
		STREET 2:		SUITE 4236
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60604

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIME ESTATES & DEVELOPMENTS INC
		DATE OF NAME CHANGE:	20091008
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cosm_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?><html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt="http://fasb.org/srt/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:cosm="http://cosm.com/20220719"><head><title>cosm_8k.htm</title><!--Document Created by XBRLMaster--><meta http-equiv="Content-Type" content="text/html" /></head><body style="text-align:justify;font:10pt times new roman"><div style='display:none;text-align:justify;font:10pt times new roman;margin-left:7%;margin-right:7%;' id='XBRLDIV'><ix:header><ix:hidden><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="From2022-07-19to2022-07-19">0001474167</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="From2022-07-19to2022-07-19" format="ixt:booleanfalse">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type='simple' xlink:href='cosm-20220719.xsd'></link:schemaRef></ix:references><ix:resources><xbrli:context id="From2022-07-19to2022-07-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001474167</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-19</xbrli:startDate><xbrli:endDate>2022-07-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="Shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="USDPShares"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit></ix:resources></ix:header></div><table style="font-size:1px;width:100%"><tbody><tr><td style="BORDER-BOTTOM: 5px solid;"></td></tr><tr><td style="BORDER-BOTTOM: 2px solid;"></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>UNITED STATES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SECURITIES AND EXCHANGE COMMISSION</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Washington, D.C. 20549</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="font-size:18pt">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="From2022-07-19to2022-07-19">8-K</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>&#160;</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>CURRENT REPORT</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>&#160;</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Date of Report (Date of earliest event reported)&#160;<strong><ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="From2022-07-19to2022-07-19" format="ixt:datemonthdayyearen">July 19, 2022</ix:nonNumeric></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>&#160; </strong></p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:60%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:78%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><span style="font-size:18pt">&#160;<strong><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="From2022-07-19to2022-07-19">Cosmos Holdings Inc.</ix:nonNumeric></strong></span></p></td></tr><tr style="height:15px"><td style="width:78%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Exact name of registrant as specified in its charter)</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:85%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:30%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="From2022-07-19to2022-07-19" format="ixt-sec:stateprovnameen">Nevada</ix:nonNumeric></strong></p></td><td style="width:5%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:30%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:EntityFileNumber" contextRef="From2022-07-19to2022-07-19">000-54436</ix:nonNumeric>&#160;</strong></p></td><td style="width:5%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:30%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="From2022-07-19to2022-07-19">27-0611758</ix:nonNumeric>&#160;</strong></p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(State or other jurisdiction</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">of incorporation)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Commission</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">File Number)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(I.R.S. Employer</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Identification No.)</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:85%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:45%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="From2022-07-19to2022-07-19">141 West Jackson Blvd, Suite 4236</ix:nonNumeric>,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="From2022-07-19to2022-07-19">Chicago</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="From2022-07-19to2022-07-19" format="ixt-sec:stateprovnameen">Illinois</ix:nonNumeric></strong></p></td><td style="width:10%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:45%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="From2022-07-19to2022-07-19">60604</ix:nonNumeric></strong></p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Address of principal executive offices)&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Zip Code)</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Registrant&#8217;s telephone number, including area code&#160;<strong>(<ix:nonNumeric name="dei:CityAreaCode" contextRef="From2022-07-19to2022-07-19">312</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="From2022-07-19to2022-07-19">865-0026</ix:nonNumeric></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>&#160;</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>N/A</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Former name or former address, if changed since last report.)</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Securities registered pursuant to Section 12(b) of the Act:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;border-right:#000000 1px solid;border-bottom:#000000 1px solid;text-align:justify;margin-left:auto;margin-right:auto;width:100%" cellpadding="2"><tbody><tr style="height:15px"><td style="border-top:#000000 1px solid;border-left:#000000 1px solid;padding:2px;width:26%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Title of Each Class</p></td><td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:26%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Trading Symbol</p></td><td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:26%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Name of Each Exchange</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">On Which Registered</p></td></tr><tr style="height:15px"><td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:26%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric name="dei:Security12bTitle" contextRef="From2022-07-19to2022-07-19">Common Stock, par value $.001</ix:nonNumeric></p></td><td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:26%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric name="dei:TradingSymbol" contextRef="From2022-07-19to2022-07-19">COSM</ix:nonNumeric></p></td><td style="border-top:#000000 1px solid;padding-bottom:2px;padding-top:2px;padding-left:2px;border-left:#000000 1px solid;padding-right:2px;padding:2px;width:26%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">The <ix:nonNumeric name="dei:SecurityExchangeName" contextRef="From2022-07-19to2022-07-19" format="ixt-sec:exchnameen">Nasdaq</ix:nonNumeric> Capital Market</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="From2022-07-19to2022-07-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td><td style="vertical-align:top;"><p style="margin:0px">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="From2022-07-19to2022-07-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td><td style="vertical-align:top;"><p style="margin:0px">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="From2022-07-19to2022-07-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td><td style="vertical-align:top;"><p style="margin:0px">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="From2022-07-19to2022-07-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td><td style="vertical-align:top;"><p style="margin:0px">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13a-4(c))</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b of this chapter).</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in;text-indent:0.5in">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="From2022-07-19to2022-07-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><table style="font-size:1px;width:100%"><tbody><tr><td style="BORDER-BOTTOM: 2px solid;"></td></tr><tr><td style="BORDER-BOTTOM: 5px solid;"></td></tr></tbody></table><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="TEXT-INDENT: 0px;"></td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Item 8.01</span>&#160;<span style="text-decoration:underline">Other Events</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On July 19, 2022, Cosmos Holding, Inc. (the &#8220;<strong>Company</strong>&#8221;) entered into a binding letter of intent (the &#8220;<strong>LOI</strong>&#8221;) to acquire Pharmaceutical Laboratories Cana, S.A. (&#8220;<strong>Cana</strong>&#8221;), a company organized under the laws of Greece through our purchase of one hundred (100%) percent of the shares of Cana Laboratories Holding (Cyprus) Limited (the &#8220;<strong>SPV</strong>&#8221;).&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Founded in 1928, Cana has manufactured and distributed a broad range of proprietary pharmaceutical and health related products.&#160; Furthermore, it has operated as a trusted partner of multinational pharmaceutical companies, such as AstraZeneca, Janssen, Merck and Viatris, as well as some of the largest Fast Moving Consumer Goods (FMCG) companies, such as Nestle, Unilever and P&amp;G.&#160; In the last decade, Cana Laboratories&#8217; activities also ventured into medical devices, representing major medical technology companies, such as Medtronic, Stryker and others in the Greek market.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cana&#8217;s 54,000 square foot owned production site, located in Athens, Greece, is European Good Manufacturing Practices (GMP) certified by <span style="text-decoration:underline">EMA</span> to manufacture pharmaceuticals, food supplements, cosmetics, biocides and medical devices.&#160; It has a variety of production lines that can service solid, orals, semi solids and liquids.&#160; Cana is ISO 9001:2015 certified.&#160; Cana&#8217;s diversified customer base includes public and private hospitals, pharmacies, supermarkets, wholesalers, etc.&#160; Furthermore, its proprietary product portfolio includes pharmaceuticals, dermocosmetics, antiseptics, and food supplements, as well as its infant care organic product line, Biobebe.&#160; Total consideration for the proposed acquisition consists of &#8364;1,700,000 in cash and 433,334 shares of Cosmos common stock, at an issuance price of $3.00 per share ($1,300,000 in total), both paid to the shareholders of the SPV.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The SPV will first acquire one hundred (100%) percent of the outstanding capital stock of Cana, in accordance with Cana&#8217;s objections under a Restructuring Plan submitted to the Greek Courts of Law on December 20, 2021 (the &#8220;<strong>Pre Pack Agreement</strong>&#8221;).&#160; Cosmos will issue a Secured Note to the SPV (subject to the SPV having acquired Cana to be paid within thirty (30) days of the date of ratification by the Greek Courts of the Pre Pack Agreement), amounting to &#8364;4,000,000.&#160; The Secured Note will have a five-year Maturity Date and shall accrue fixed interest at five (5%) percent per annum.&#160; The Secured Note will be secured by (1) a pledge over all of the SPV&#8217;s shares currently held by the SPV owners and (2) a Security Agreement over the SPV&#8217;s assets (including 100% of the shares of Cana and Cana&#8217;s assets).&#160; The proceeds of the Secured Note are to be used to pay approximately &#8364;3,300,000 of debt and the remaining &#8364;700,000 for working capital.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">From the signing of the Secured Note and the disbursement of any funds until Closing, the SPV Sellers will be prohibited from entering into any other transaction, such as the issuance of new capital shares and the signing of any equity mechanism, such as a convertible note or bond.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Pursuant to a Securities Purchase Agreement (the &#8220;<strong>SPA</strong>&#8221;) with the SPV owners, Cosmos shall pay them an aggregate of &#8364;1,700,000, of which &#8364;1,200,000 shall be held in a U.S.-based escrow account upon the signing of the SPA to be held until closing, and &#8364;500,000 will be paid in cash within one hundred twenty (120) days of the signing of the SPA.&#160; Under the SPA, the Company will issue $1,300,000 in Cosmos Common Stock, consisting of 433,334 restricted shares, at an issuance price of $3.00 per share.&#160; In the event that upon closing of the SPA, the market price would be higher than $3.00 per share, then the number of shares and the issuance price will be adjusted at the market price to equal $1,300,000.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Certain current managers of Cana will remain managing directors of Cana.&#160; The parties will negotiate in good faith customary service agreements for the managing directors, whereby the parties agree that the economic terms of such new agreements shall be equal or more favorable for the managing directors compared to their current service agreements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The parties agreed to an Exclusivity Period from the signing of the LOI until thirty (30) days past the date of Court Approval of the Pre Pack Agreement.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">-2-</p></td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cosmos&#8217; obligations to close the proposed Transaction upon the execution of the definitive SPA, Secured Note, the Pledge and Security Agreement, the Escrow Agreement and other Transaction Documents will be subject to:&#160; (1) the SPV having acquired Cana; (2) ratification by the Greek Courts of the Pre Pack Agreement; and (3) customary closing conditions, including, but not limited to: (a) Cosmos&#8217; satisfactory completion of due diligence, (b) the approval of the Transaction by the Board of Directors and/or the stockholders of Cosmos and Cana, if required, and (c) confirmation from Cosmos&#8217; auditors that the financial statements of Cana and the SPV can be audited in accordance with PCAOB and SEC rules and regulations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Item 9.01</span> <span style="text-decoration:underline">Financial Statement Exhibits</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Exhibit Index</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;width:8%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Exhibit No.</strong></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>&#160;</strong></p></td><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Description</strong></p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="cosm_ex101.htm">10.1</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="cosm_ex101.htm">Binding Letter of Intent dated July 19, 2022 by and among Cosmos Holdings, Inc., Pharmaceutical Laboratories Cana, S.A., and Cana Laboratories Holding (Cyprus) Limited.</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="cosm_ex991.htm">99.1</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="cosm_ex991.htm">Press Release dated July 20, 2022, titled &#8220;Cosmos Holdings Announces Agreement to Acquire Cana Laboratories, a Legacy European Pharmaceutical Company Established in 1928; Vertically Integrating its Manufacturing and R&amp;D Capabilities and Expanding its Product Pipeline with New Brands.&#8221;</a></p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td>104&#160;</td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Cover Page Interactive Data File (embedded within the Inline XBRL Document).</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">-3-</p></td></tr><tr style="height:15px"><td><p style='page-break-after: always'></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SIGNATURES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>COSMOS HOLDINGS INC.</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="width:50%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:3%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:35%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:12%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Date: July 25, 2022&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">By:</p></td><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><em>/s/ Grigorios Siokas</em></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Grigorios Siokas</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Chief Executive Officer</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">-4-</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>cosm_ex101.htm
<DESCRIPTION>BINDING LETTER OF INTENT
<TEXT>
<html><head><title>cosm_ex101.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman; MARGIN-LEFT: 7%; MARGIN-RIGHT: 7%"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 10.1</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>&nbsp; </strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><u>BINDING </u></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><u>LETTER OF INTENT (LOI)</u></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">This Letter of Intent (&#8220;LOI&#8221;) sets forth the terms and conditions for a proposed acquisition and financing by <strong>Cosmos Holdings, Inc.</strong> (&#8220;<strong>Cosmos</strong>&#8221;), a corporation organized under the laws of the State of Nevada, with Company I.R.S number (27-0611758),located at 141 West Jackson Boulevard, Suite 4236, Chicago, IL 60604, of <strong>Pharmaceutical Laboratories Cana S.A. </strong>(the &#8220;<strong>Company</strong>&#8221;), a company organized under the laws of Greece with Company number (&#915;&#917;&#924;&#933;) 237301000, VAT number 094007210, located at 446 Irakliou Avenue, Iraklio 14122, Attica, Greece, via the acquisition of <strong>Cana Laboratories Holding (Cyprus) Limited</strong> (<strong>SPV</strong>), a corporation organized under the laws of Cyprus, with Company number HE341107, VAT number 10341107U located at Arsinois 12, Agia Marina Chrisochous, 8881 Paphos from the owners of the SPV (the &#8220;<strong>SPV Owners</strong>&#8221;, together with the SPV and the Company, the &#8220;<strong>Sellers</strong>&#8221;).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">Company is the owner of a fully licensed, operational GMP (Good Manufacturing Practices) facility that manufactures health products under the following categories of the Greek Regulatory Authorities: (a) Pharmaceuticals, (b) Food Supplements, (c) Cosmetics, (d) Medical Devices and (e) Biocides. The afore-mentioned license categories permit the Company to manufacture subcategories of products such as nutraceuticals and dermocosmetics.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">This LOI is intended to be a binding agreement setting out the basic terms of the acquisition and financing, and shall be superseded by a definitive Sales and Purchase Agreement (&#8220;<strong>SPA</strong>&#8221;) and Secured Promissory Note (&#8220;<strong>Secured Note</strong>&#8221;) and related transaction documents as described herein (&#8220;<strong>Transaction Documents</strong>&#8221;) entered by the parties governing the Transaction (as defined below).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:20%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Transaction:</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The overall transaction as described below (the &#8220;<strong>Transaction</strong>&#8221;) shall consist of two simultaneous transactions:&nbsp; (1) pursuant to the Secured Note, Cosmos shall provide financing to the SPV; and (2) pursuant to the SPA, Cosmos shall, directly or indirectly through a subsidiary, acquire all of the outstanding shares of capital stock of the SPV (the &#8220;<strong>SPV Shares</strong>&#8221;), free and clear of all encumbrances, in exchange for cash and shares of Cosmos stock (Nasdaq COSM), payable (and/or issued) to the SPV Owners&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Due to the time sensitivity of the Transaction (in relation to the Company&#8217;s obligations borne by the Restructuring Plan submitted to the Greek Courts of Law on December 20<sup style="vertical-align:super">th</sup> 2021 (Pre Pack Agreement), the SPV first will acquire the totality of the outstanding shares of capital stock of the Company, free and clear of all encumbrances, thus undertaking to execute the obligations, within the timelines, as established in the Pre Pack Agreement. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cosmos will issue a&nbsp; Secured Note to the SPV (subject to the SPV having acquired the Company and within 30 days of the date of ratification by the Greek Courts of the Pre Pack Agreement and subject to such acquisition and ratification), amounting to &#8364;4,000,000, whose use of proceeds are defined in Annex 1 attached to this LOI.&nbsp; The Secured Note will have a 5-year Maturity Date and shall accrue fixed interest at 5% per annum.&nbsp; </p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr></table></p> <p style="margin:0px"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;&nbsp; </p> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">-1-</p></td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;&nbsp; </p> <p style="margin:0px"> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:20%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Secured Note will be secured by (1) a Share Pledge over the SPV&#8217;s shares by the SPV Owners and (2) a Pledge over the SPV&#8217;s assets (including 100% of the shares of the Company and the Company&#8217;s assets) (together, the &#8220;<strong>Pledge Agreements</strong>&#8221;).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The SPA will be signed by Cosmos, the SPV Owners and the SPV with terms as described below.</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The closing of the Transaction has to be completed by December 31<sup style="vertical-align:super">st</sup> 2022 (the &#8220;<strong>Closing</strong>&#8221;).</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Due Diligence:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Further to the documents and information already shared with Cosmos following the Confidentiality Agreement signed by the Parties on December 17<sup style="vertical-align:super">th</sup> 2021, from and after the date of this LOI, the SPV&#8217;s management and the Company&#8217;s management shall allow Cosmos and its advisors full access to the SPV&#8217;s and the Company&#8217;s facilities, records, key employees and advisors for the purpose of completing Cosmos&#8217;s due diligence review. The due diligence investigation will include, but is not limited to, a complete review of the SPV&#8217;s and the Company&#8217;s financial, legal, tax, environmental, intellectual property and labor records and agreements, and any other matters as Cosmos&#8217;s accountants, tax and legal counsel, and other advisors deem necessary.&nbsp; For the avoidance of doubt, the due diligence shall include a PCAOB audit of the Company and the SPV.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">SPA Purchase Price:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cosmos, the SPV Owners and the SPV (that shall own 100% of the Company prior to signing of the SPA) agree that the purchase price for 100% of the Shares of the SPV pursuant to the SPA, shall be &#8364;1,700,000 paid in cash to the SPV Owners plus $1,300,000 paid in Cosmos&#8217;s common stock to the SPV Owners, as defined in Annex 2.&nbsp; Cosmos shall deposit the cash portion of the purchase price into a U.S. based escrow account for the benefit of the SPV Owners to be released at Closing pursuant to an escrow agreement (the &#8220;<strong>Escrow Agreement</strong>&#8221;).&nbsp; [Cosmos] will cover the costs of the escrow.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Conditions:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cosmos&#8217;s obligation to close the proposed Transaction via the execution of the definitive SPA, Note and other Transaction Documents will be subject to:&nbsp; (1) the SPV having acquired the Company; (2) ratification by the Greek Courts of the Pre Pack Agreement; and (3) customary conditions; including, but not limited to: (a) Cosmos&#8217;s satisfactory completion of due diligence, (b) the approval of the Transaction by the Board of Directors and/or the stockholders of Cosmos and the Company, (c) confirmation from Cosmos&#8217;s auditors that the financial statements of the Company and the SPV can be audited in accordance with PCAOB and SEC rules and regulations.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Management Condition:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Parties agreed that certain current managers of the Company and the SPV will remain managing directors of the Company and the SPV. Parties will negotiate in good faith customary service agreements for the managing directors, whereby the Parties agree that the economic terms of such new agreements shall be equal or more favorable for the managing directors compared to their current service agreements.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;&nbsp;&nbsp; </p> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">-2-</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="margin:0px"> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:20%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Definitive Agreements:</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In addition to the provisions specifically described herein, the SPA, the Secured Note, the Pledge Agreements, the Escrow Agreement and any other Transaction Documents will contain standard representations, warranties, survival periods, indemnification, limits on indemnification, covenants, termination rights and other provisions appropriate for a transaction of the type contemplated herein, , as may be required under US securities Rule 144.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Exclusivity:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In consideration of the expenses that Cosmos has incurred and will incur in connection with the proposed Transaction, the Company and the SPV agree to define the &#8220;Exclusivity Period&#8221; as the period from signing of the LOI until 30 natural days post the date of the Court Approval of the Pre Pack Agreement. During the Exclusivity Period, neither the Company, the SPV, the SPV Owners, nor any of their respective representatives, officers, employees, directors, agents, stockholders, subsidiaries or affiliates (the &#8220;Seller Group&#8221;) shall initiate, solicit, entertain, negotiate, accept or discuss, directly or indirectly, any proposal or offer from any person or group of persons other than Cosmos and its affiliates (an &#8220;Acquisition Proposal&#8221;) to acquire all or any significant part of the business and properties, capital stock or capital stock equivalents of the Company and the SPV, whether by merger, purchase of stock, purchase of assets, tender offer or otherwise, or provide any non-public information to any third party in connection with an Acquisition Proposal or enter into any agreement, arrangement or understanding requiring it to abandon, terminate or fail to consummate the Transaction with Cosmos. The Company and the SPV each agrees to immediately notify Cosmos if any member of the Seller Group receives any indications of interest, requests for information or offers in respect of an Acquisition Proposal, and will communicate to Cosmos in reasonable detail the terms of any such indication, request or offer, and will provide Cosmos with copies of all written communications relating to any such indication, request or offer. Immediately upon execution of this LOI, the Company, the SPV and the SPV Owners shall, and shall cause the Seller Group to, terminate any and all existing discussions or negotiations with any person or group of persons other than Cosmos and its affiliates regarding an Acquisition Proposal. The Company, the SPV and the SPV Owners each represents that no member of the Seller Group is party to or bound by any agreement with respect to an Acquisition Proposal other than under this LOI.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expenses:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cosmos agrees that the audit and due diligence shall be conducted at its sole expense.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Confidentiality:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The parties acknowledge that Cosmos is publicly traded on the U.S. NASDAQ (ticker symbol: COSM), and this LOI or a respective press release may be published or otherwise filed with the Securities and Exchange Commission, further approval by the Company. Any other obligations for non-disclosure are governed by the Confidentiality Agreement signed by the Parties on December 17, 2021.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;&nbsp; </p> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">-3-</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="margin:0px"> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:20%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Expiration; Termination:</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">This LOI will remain in effect until 11:59 PM, New York time, on December 31, 2022, unless earlier terminated by the mutual written agreement of the parties.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Governing Law; Forum</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">This LOI shall be governed by and construed in accordance with the internal laws of the State of New York, without giving effect to any choice or conflict of law provision or rule (whether of the State of New York or any other jurisdiction) that would cause the application of laws of any jurisdiction other than those of the State of New York.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The parties hereby consent to the concurrent jurisdiction exclusive jurisdiction of the courts of the State of New York and the United States located in New York County, New York in connection with any suit, action or proceeding arising out of or relating in any manner to this LOI, and each of the parties further irrevocably agree to waive any objection to the venue of any such suit or proceeding in either court, or to in personam jurisdiction.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Miscellaneous:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">This LOI may be executed in counterparts, each of which shall be deemed to be an original, but all of which together shall constitute one agreement. The headings of the various sections of this LOI have been inserted for reference only and shall not be deemed to be a part of this LOI.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">This LOI contains the entire agreement and understanding between the parties hereto with respect to the subject matter hereof, and supersedes all prior and contemporaneous agreements, understandings, inducements and conditions, express or implied, oral or written, of any nature whatsoever with respect to the subject matter hereof (with the express exclusion of the Confidentiality Agreement signed on December 17<sup style="vertical-align:super">th</sup>, 2021). The express terms hereof control and supersede any course of performance and/or usage of the trade inconsistent with any of the terms hereof.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Third Party Beneficiaries:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Except as specifically set forth or referred to herein, nothing herein is intended or shall be construed to confer upon any person or entity other than the parties and their successors or assigns, any rights or remedies under or by reason of this LOI.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">[no further text on this page]</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"> <p style="MARGIN: 0px; text-align:center;">-4-</p></td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;&nbsp; &nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">If you agree with the terms set forth above and desire to proceed with the proposed Transaction on that basis, please sign this LOI in the space provided below.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Dated: July 19, 2022</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td></td> <td colspan="2" style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>COSMOS HOLDINGS, INC.</strong></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>&nbsp;</strong></p></td></tr> <tr style="height:15px"> <td style="width:50%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:5%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:35%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:10%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">By:</p></td> <td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><em>/s/ Grigorios Siokas</em></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Name:</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Grigorios Siokas</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Title:</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">CEO</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr></table></p> <p style="margin:0px"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Agreed and Accepted:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>PHARMACEUTICAL LABORATORIES CANA S.A.</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:5%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">By:</p></td> <td style="BORDER-BOTTOM: #000000 1px solid;width:35%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><em>/s/ Konstantinos-Gaston Kanaroglou</em></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Name:</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Konstantinos-Gaston Kanaroglou</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Title: </p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">President &amp; CEO</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr></table></p> <p style="margin:0px"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>CANA LABORATORIES HOLDING (CYPRUS) LIMITED</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>&nbsp;&nbsp; </strong></p> <p style="margin:0px"> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:5%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">By:&nbsp; &nbsp;</p></td> <td style="BORDER-BOTTOM: #000000 1px solid;width:35%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><em>/s/ Dimitra Tsogka&nbsp;</em></p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;&nbsp;</p></td> <td style="width:5%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">By: &nbsp;</p></td> <td style="BORDER-BOTTOM: #000000 1px solid;width:35%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><em>/s/ Konstantinos-Gaston Kanaroglou&nbsp;</em></p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Name: &nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Dimitra Tsogka&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Name:&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Konstantinos-Gaston Kanaroglou&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Title: &nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Legal Representative&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Title:&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Owner&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">By:</p></td> <td style="BORDER-BOTTOM: #000000 1px solid;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><em>/s/ Konstantina-Mathilde Kanaroglou</em></p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">Name:</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">Konstantina-Mathilde Kanaroglou</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">Title:</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">Owner</p></td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">-5-</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Annex 1</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Secured Note</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><u>Secured Note characteristics:</u></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">1.</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Amount: &#8364;4,000,000</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">2.</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Disbursement Maturity: 30 days after ratification date of the Pre Pack Agreement by the Greek court and acquisition of the Company by the SPV.</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">3.</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Restrictions: from the signing of the Secured Note and the disbursement of the above-mentioned amount and until Closing, the Sellers will be prohibited from entering into any other transaction such as the issuance of new capital shares and the signing of any equity mechanism like convertible note or bond etc.</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">4.</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Maturity Date and Interest: 5 years from disbursement with interest fixed at 5% per annum.</p></td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Use of Proceeds of the Secured Note:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">1.</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&#8364;4,000,000 will be used as a capital increase to the Company to cover:</p></td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:8%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">a.</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Payment of &#8364;2,700,000 to Cepal within 2 months (30 days specified by the Pre Pack Agreement plus a further 30 days allowance specified by Greek Law) of the date of ratification of the Pre Pack Agreement by the Greek Courts.</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">b.</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Payment of &#8364;600,000 to insurance funds EFKA, TAYFE and TEAYFE, (the exact amount will be determined depending on the date of ratification of the Pre Pack Agreement by the Greek Courts) within 2 months of the date of ratification of the Pre Pack Agreement by the Greek Courts.</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">c.</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Remaining &#8364;700,000 shall be used as working capital by the Company.</p></td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">[no further text on this page]</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">-6-</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Annex 2</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SPA</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><u>Paid in Cash : &#8364;1,700,000</u></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">1.</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">The amount of &#8364;1,200,000 will be paid in cash into an escrow account upon the signing of the SPA between Cosmos and the SPV Owners.</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">2.</p></td> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">The amount of &#8364;500,000 will be paid in cash within 120 days of the signing of the SPA between Cosmos and the owners of the SPV.</p></td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><u>Paid in Stock: $1,300,000</u></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At Closing, #433,334 Restricted Cosmos Stock (as defined below) for the amount of $1,300,000 at an issuance price of $3.00 per share will be issued&nbsp; the SPV Owners. In the event that at Closing of the SPA the market price would be higher than $3.00 per share, then the number of shares and the issuance price will be adjusted at the market price accordingly to the amount of $1,300,000. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Restricted Cosmos Stock has the following characteristics: SEC Rule 144 requires a selling security holder to hold shares of a reporting company for&nbsp;six months after the securities are fully paid.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">[no further text on this page]</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp; </p> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">-7-</td></tr></table></p> <p style="margin:0px"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>cosm_ex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<html><head><title>cosm_ex991.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman; MARGIN-LEFT: 7%; MARGIN-RIGHT: 7%"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 99.1</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;text-align:left;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:30%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><img src="cosm_ex991img1.jpg"></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:30%;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><img src="cosm_ex991img2.jpg"></p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0cm; text-align:justify;">&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>&nbsp;</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Cosmos Holdings Announces Agreement to Acquire Cana Laboratories, a Legacy European Pharmaceutical Company Established in 1928;</strong><strong>Vertically Integrating its Manufacturing and R&amp;D Capabilities and Expanding its Product Pipeline with New Brands</strong><strong> </strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>CHICAGO, July 20, 2022&nbsp; -- </strong>Cosmos Holdings, Inc.<strong> (&#8220;the Company") (Nasdaq: </strong>COSM<strong>)</strong><strong>, </strong>an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, today announced that it has entered into a binding letter of intent to acquire Pharmaceutical Laboratories CANA S.A., (&#8220;Cana&#8221;)<strong> </strong>a Greek pharmaceutical company that manufactures, sells, distributes, and markets original branded products researched and developed by leading global pharmaceutical and healthcare companies. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Founded in 1928, Cana has manufactured and distributed a broad range of proprietary pharmaceutical and health related products. Furthermore, it has operated as a trusted partner of multinational pharmaceutical companies such as AstraZeneca, Janssen, Merck and Viatris as well as some of the largest Fast Moving Consumer Goods (FMCG) companies such as Nestle, Unilever and P&amp;G. In the last decade, Cana Laboratories&#8217; activities also ventured into medical devices, representing major medical technology companies such as Medtronic, Stryker and others in the Greek market.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cana&#8217;s 54,000 sq. ft owned production facility&nbsp; located in Athens, Greece, is licensed under European Good Manufacturing Practices (GMP) and certified by EMA to manufacture pharmaceuticals, food supplements, cosmetics, biocides and medical devices. It has a variety of production lines that can produce solids, orals, semi solids and liquids. The company is ISO 9001:2015 certified.&nbsp; Cana&#8217;s diversified customer base includes public &amp; private hospitals, pharmacies, supermarkets, wholesalers, etc. Furthermore, its proprietary product portfolio includes pharmaceuticals, dermocosmetics, antiseptics, and food supplements, as well as an infant care organic product line, Biobebe. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Kosta Kanaroglou, CEO of Cana Laboratories, stated, &#8220;We are pleased to be joining the Cosmos team as they share our dedication to health and wellness, as well as our high quality product standards. Cana is a 4th generation family business with the vision&nbsp; to serve the community by developing, manufacturing and distributing products that offer innovative solutions to patients, while adhering to the highest standards of business ethics. This acquisition should allow Cana to grow its contract manufacturing customer base, reposition its existing product portfolio and invest in new proprietary products. We look forward to being part of the Cosmos family and assisting in the development and launching of innovative pharmaceutical products together.&#8221;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Greg Siokas, Chief Executive Officer of Cosmos Holdings, commented, &#8220;We welcome Cana to our group, an acquisition that delivers on our commitment to grow via strategic M&amp;As. We believe this acquisition not only will allow us to realize numerous synergies but will also be a transformative for Cosmos by strengthening our vertical integration and expanding our product portfolio. Cana&#8217;s extensive commercial experience and diversified customer base will also prove to be invaluable as we execute on relaunching and expanding several brands. We look forward to working with Kosta Kanaroglou and his team to build upon Cosmos&#8217; success.&#8221;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">1</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Additional details on the transaction will be available in the Company&#8217;s Form 8-K to be filed with the U.S. Securities and Exchange Commission.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>About Pharmaceutical Laboratories CANA S.A.</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Pharmaceutical Laboratories CANA S.A. is a Greek company founded in 1928, that manufactures and distributes a wide range of pharmaceutical and health related products, both proprietary as well as in partnership with multinational companies. More information about Cana can be found at www.cana.gr. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>About Cosmos Holdings, Inc.</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cosmos Holdings Inc. (Nasdaq: COSM) is an international healthcare group that was incorporated in 2009 and is headquartered in Chicago, Illinois. The group in engaged in the nutraceuticals sector through its own proprietary lines of products &#8220;Sky Premium Life&#8221; and &#8220;Mediterranation&#8221;. Cosmos Holdings Inc. is operating in the pharmaceutical sector as well, through the provision of a broad line of branded generics and OTC medications. In addition, the group is involved in the healthcare distribution sector through its subsidiaries in Greece and UK serving retail pharmacies and wholesale distributors. Cosmos Holdings Inc. is strategically focusing on the R&amp;D of novel patented nutraceuticals (IP) and specialized root extracts as well as on the R&amp;D of proprietary complex generics and innovative OTC products. Cosmos has developed a global distribution platform and is currently expanding throughout Europe, Asia and North America. Cosmos Holdings has offices and distribution centers in Thessaloniki and Athens, Greece and Harlow, UK. More information is available at www.cosmosholdingsinc.com and www.skypremiumlife.com.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Forward-Looking Statements</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">With the exception of the historical information contained in this news release, the matters described herein, may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements preceded by, followed by, or that otherwise, include the words &#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;intends,&#8221; &#8220;projects,&#8221; &#8220;estimates,&#8221; &#8220;plans&#8221; and similar expressions or future or conditional verbs such as &#8220;will,&#8221; &#8220;should,&#8221; &#8220;would,&#8221; &#8220;may&#8221; and &#8220;could&#8221;, are generally forward-looking in nature and not historical facts, although not all forward-looking statements include the foregoing. These statements, involve unknown risks and uncertainties that may individually or materially impact the matters discussed, herein for a variety of reasons that are outside the control of the Company, including, but not limited to, the Company&#8217;s ability to raise sufficient financing to implement its business plan, the impact of the COVID-19 pandemic and the war in Ukraine, on the Company&#8217;s business, operations and the economy in general, and the Company&#8217;s ability to successfully develop and commercialize its proprietary products and technologies. Readers are cautioned not to place undue reliance on these forward- looking statements, as actual results could differ materially from those described in the forward-looking statements contained herein. Readers are urged to read the risk factors set forth in the Company&#8217;s filings with the SEC, which are available at the SEC&#8217;s website (www.sec.gov). The Company disclaims any intention or obligation to update, or revise any forward-looking statements, whether as a result of new information, future events or otherwise.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Investor Relations Contact:</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Crescendo Communications, LLC</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Tel: 212-671-1020</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Email: COSM@crescendo-ir.com </p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp; </p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">2</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>cosm-20220719.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 07/23/2022-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2022 I-NET Business Solutions, Inc. All Rights Reserved.-->
<schema xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:us-gaap-att="http://fasb.org/us-gaap/attributes" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt-roles="http://fasb.org/srt-roles/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:srt="http://fasb.org/srt/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:cosm="http://cosm.com/20220719" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://cosm.com/20220719">
 <annotation>
  <appinfo>
   <link:roleType roleURI="http://cosm.com/role/Cover" id="Cover">
    <link:definition>000001 - Document - Cover</link:definition>
    <link:usedOn>link:presentationLink</link:usedOn>
    <link:usedOn>link:calculationLink</link:usedOn>
    <link:usedOn>link:definitionLink</link:usedOn>
   </link:roleType>
   <link:linkbaseRef xlink:type="simple" xlink:href="cosm-20220719_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
   <link:linkbaseRef xlink:type="simple" xlink:href="cosm-20220719_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
   <link:linkbaseRef xlink:type="simple" xlink:href="cosm-20220719_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
   <link:linkbaseRef xlink:type="simple" xlink:href="cosm-20220719_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
  </appinfo>
 </annotation>
 <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
 <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
 <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
 <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
 <import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd" />
 <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
 <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
 <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
 <import namespace="http://xbrl.sec.gov/exch/2022" schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd" />
 <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
 <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
 <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
 <import namespace="http://xbrl.sec.gov/naics/2022" schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" />
 <import namespace="http://xbrl.sec.gov/sic/2022" schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd" />
 <import namespace="http://fasb.org/srt-roles/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd" />
 <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
 <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
 <import namespace="http://xbrl.sec.gov/stpr/2022" schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" />
 <import namespace="http://fasb.org/us-roles/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd" />
 <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
 <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
 <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>cosm-20220719_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 07/23/2022-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2022 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
  <link:roleRef xlink:type="simple" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address Address Line 1</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address City Or Town</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address State Or Province</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Security 12b Title</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>cosm-20220719_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 07/23/2022-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2022 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef  roleURI="http://cosm.com/role/Cover" xlink:href="cosm-20220719.xsd#Cover" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://cosm.com/role/Cover" xlink:title="00000001 - Document - Document and Entity Information" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>cosm-20220719_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 07/23/2022-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2022 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://cosm.com/role/Cover" xlink:href="cosm-20220719.xsd#Cover" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://cosm.com/role/Cover" xlink:title="00000001 - Document - Cover Page Information">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
    <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>cosm-20220719_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 07/23/2022-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2022 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef  roleURI="http://cosm.com/role/Cover" xlink:href="cosm-20220719.xsd#Cover" xlink:type="simple" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <link:definitionLink xlink:type="extended" xlink:role="http://cosm.com/role/Cover" xlink:title="00000001 - Document - Cover Page Information">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCover" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>cosm_ex991img1.jpg
<TEXT>
begin 644 cosm_ex991img1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1"  S (H# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#V_4M8U;QE
M\4;CP+I>I3Z9HVDQ";5+BU;9-.QQB%7'*#D9(YX;GI6]>?"OP/=6QB71?LMQ
MCY;V"5UN%/\ >\S.XGZY%<+X>N4\%_M#^)+'6F^S6WB(>?9W,G"2,6W!<].I
M=?J .XKVV>XAM;>2XN9DAAC4L\DC!54#J23T%244?#NFW6C^&]/TV]OI+^YM
MH1')<R,6:4CN2>:\^TO4IOB)\1=?L[F>5?#>@N+1+6&4HMY.2P9I"I!91M.%
MZ=#ZUZ%X?US3_$>@VNMZ:7-I= F,NNTD!BO3Z@UY)\-9/^$7^+WC7PGJQ$,^
MHW/VZR9_E\]"SGY3W.UQP/[K>E C8\;?#^STO0+[Q!X)DE\/:QIT37*M92,B
M3J@W,CIG:<C...N,Y'%=1\._$TGB[P#INNSJ$N95*3A1@>8C%6('8'&?QIWC
M_6+70_ VLWES( SVSP0IWDE=2J*!W))_+/I57X4>';OPQ\,-)TS4(S%>%6GF
MC/!1G8MM/N 0#[@U0SDM8UKP]J'QBU/P[X\NDBTV"U@_LRUNI"EK,S#,COR%
M9LD!=W'!QS7;^&?"</AG5;Z;1[ITT2[AB,5AYC/'!("VYH\D@*P*\#T^E9^K
M:'X+^(U]JFD:UIHGO=&F%NTF[9,@9%<,K*<[3NZ'C*GBN2^&5G>^&?BEXF\$
MV.J7&I>'K*V2>/SFW?9I6*X3(X!P6SC&=N<5('9?%+2;74O &I2R I=6T1:U
MG61D:)R0 <CMG&?:L3X0^([Z\T.^\(Z](QUSP[,;64NV6DCR0K9/7&"N?0*>
M]=#\4&*_#C5#G'SVX_ SQ@UP'Q&6;P#\4-(^)EC&QTZ](L=6CC'48X;'<E0"
M/>,>M BS\>-<U./PQ-I&B2-%]F6*\U&5&*E(VD$<29'=FR?I&:]*\(VMO8^#
M]*AMX_+1K6.0C).690223W)->5>/;*Z_X43XB\0:E$4U#7+B"]E1NL,7FH(8
MC_NQA<_[1;UKU[PRP?PAHKJ<AK& @CO^[% '!:MK=[XF^+R^ ;2\FL]+T^U^
MVZF]O(8Y9R=NV(,.57YT)P<G)'%:.M?#'P[>64S:/$VBZN%+6]_92O%(C]BQ
M!^89ZY_#!KDY'7PC^U!-J6ID0:?XDL1#!<OP@D C&W/3.8P/^!KZU['J.H6>
MDZ9<ZEJ$RP6MM&9))&. JB@9Y_\ !_Q?J?BKPE<0ZXV_5=*N#:3R<9E &58X
M[]0?7&>]4/B%X@T^S^(GA[0_%5Y):^&KFWEFD(D9(IYP<*LI7G8!@XZ989XI
M_P $M'O;/PUJFO7\#6[Z[?/>11.,,(OX2?J2Q^F#WKIM<A\*^*M<N/ _B#3X
M[R>.T2^19>#M9F3*$'<""O)&/O"@"OH?@_1=-UZTU[P?<1VFERPR)<VEK*6M
M[@G;L=0"5!&#R.H-=Y7@NB^'Y/AW\=-*\/\ AG4KF?2-6MI)[RPE?>+<*K8<
M^G(&">>HR<U[U5$G(:Q_PC^O:\/".M:*-0D^S_;!Y\*M&J;MNX-G(.>.!G\*
MQ=#\)>!;ZZOK>'PW,RZ7<_9WCOYGGB$@56^57D9<;64].]6;ZP>\^+T4C&_M
MX!HQB\^WWHID\[=L+@8SCG&:L^"86MK[Q/"RW>'U0RQR7*OF1/(B7<&8#<-R
ML/PH*.BNKRUTG36N9V%O;P@#[O Y "@#J22  .I( KF-:D\+ZYJ5AI?BKP_)
M&]P^RQGO;=0K28SL2122C$ D E2<<<BM#QM;7DVAVUQ86CW<EC?VUXUO&,O+
M''*K.%'=L9('<@54\0*OB2#2K+38Y9"-1MKN25HF06Z12"0D[@,,=NT#K\WH
M#02:MGX/\.V=[%>QZ;YMS!_J9;F5[AHO]PR,VW\,5+I.N6^L76I6UO:W$3:=
M<&UF:55 \P*K8&"<_*RG/O6[7">&KZ*PU#Q,UW#=1?:-7>:+-K*?,3R8E#+A
M>1E2/P- &CJW@GPMK.I'4-0T=#>E=K7,#O!*P]"\94D?4]JR-.UCPSX4M]5L
M=)\-WUG::9/LOI;>V$@1BBOO;#%W&UE.<$XKT&N T.\BT_Q1XPDNH+H"YU".
M2!1;2$S*+:)3MXY^96'U% &]J6D>'_%VC6YOH8=4T^51-%\Y\MP1D-P>1T-9
M^JP^'?\ B6^!]0TF2ZMM01FAC;YX\1%7.YBV[@E3[U<\&Z7+H7@S3-)N%"R0
M1G* Y$>6+!,_[(./PJAK:R'XD^%9EMYI(H8;Q9)$B9DC+K&%W,!@9P>OI0!K
MZYX;T7Q):1VNN:>E[!&=RQNS!<_0$9Z#K65X5O=!BMM0T/P_8S63Z5*4EL'X
M=?[I7+$;6VD @XX/3%=E7G=]IU]<1KXFT&,IK6FW-P%BD5HQ>VYE9F@8D=&&
M&5NBM@]": .A\C1/&?ARWEU'25NK"Z42I#>Q*2/0XYP?QS61-X<\&Z3/9V\^
MEM=RNY-I9222W/*\DI&[%5"\<X ''/2MOPR)!X4TE989()#:QEHI1AXR5SM8
M>HZ&L/4FN=+^)5MKEU:SRZ9-IK67GPQM(+:42[_G"Y(5A@;L8R@SVH Z'3-5
MDU":>&32[VP,.WBZC"AP<X*E20>G//''K6=XHT'PKJ5H=4\2:?#(;)"5NOF2
M6)?170AQUZ ]31HM[K%YXAU?[0S2:1'Y7V&1K?RS(6!+\GDA3@9P.O>K_B*&
MQN/#EY;ZE8S7UG-'Y<T,"L7*$@$@+SD YXYXXH QO">G^&]-N[Z/2?#UQI-[
MM1IGNT)EF0YVGS"S%A\IXW<=P*[6N*\)PZI9ZCJ-@^J7NK:/$D36ES?IB97.
M[?'OP#(  AW$9^8C)Q7:T 8]SJC0N5@L;NZ;_IG'@?FQ K.DUCQ!D"U\,R,/
M[TMPB8_"L6ZUKQ(_C;5=+TYT-G8I;/(&C7]W'(LF]MV<[AL4J,'/(([BMI?C
MOR?#MG-JUN[WBI;+,PD0>;YD4;>8H&/^>@R,<>O3/-.$Y_::]$OU-H2C'[*?
MJW_P#<>[\;R@^5IMI;_]='W']&J%H_B!)TFL8_I_^HU6O/'GV.VEN)-#D:)9
MKR)&%PG[S[,)#(1Z?ZML9QU%2MX\L8Y(([BSDC=[MK1U$BLRD=& !R0<C^7)
MXK!X1R^*<OOM^1JL1;:$?NO^;(_L/Q <G=J]NN>P X_\ATY=#\:.<R:\@^@_
M^Q%3V?C!;UM-CATN:1]1A%U"$FC(,/[O+9R!D>8,K['KQF"'QPMU<V$=IIX9
M[MX%/F7"KL$@G] >08&X[[A2^J1>\I/YL/K,EM%+Y(D_L/Q=_P!!T?D?\*/[
M#\7?]!T?D?\ "BQ\81SRSQM;Y:V666=C*D82-9IHP1DX8#R3DY&,CUQ2Z3XD
MDU?Q+9?9V,=M):W@DMR58>9#-$@8$#.,.WY]*/J<?YI?>P^L3[+[D,_L/Q=_
MT'A^1_PI?[#\7?\ 0='Y'_"L&U\9:Q&-.NM0D)M/M>IK<2)'&?.CM_-*J@!R
M&Q'SQSS[5:U+QY):ZO;OMD@M+9)S<PJR2+/^ZBDB97]/WG/(QSGC!I_5(_S2
M^]B^L2[+[D:?]C>- ?EUY/Q7_P"QI#IOCP?=UJ _4#_XW6?;>,KRQ&H-J)-U
M]GEU"01JR9"0"-@FX8[.><?6M)?&F^[2SCTF=KHW#6[1B12,K*L;%3_%C<'/
M3"Y-+ZK#I*7WL?UB;WBON0BV7C]?^8I;/]0/_B*41^/E_P"7BS?Z_P#[(J63
M5KZ_U_6--M]2@TI-+6([GC#M)O7?O;<1A/X>,'(;GBH4\<PS&)K?3I9%N&18
M&,B@/FX\@[O[I#$''IGN"*?U6*VG+[V'MWUBON1,K^/%/S0V$@_$?^S596^\
M81@^9H]O,?\ 8F"?S)K'M?'WVY[>&WT64W%P\2)&TZ ?O(I)%)/3_EBX/X>M
M*WQ"L3;M+'8RL1:K=!#*@;EHE*GDX(\Y?R/3C-K#26TW]Z?YF;K)[Q7W,Z&'
M5M;_ .7GP[+'[I-&_P#45?\ MD__ #Z-_P!\USL'BSSKZSLVTV6.:[>6&,&1
M2&DBG,4J@C^Z 7]USW%=C6GLY+[;_#_(ASC_ "K\2K]CM-QN/LT7FSA5D?8,
MN/0^M5_['TEK<9TNT/.W_4KTSMQT].***Z3,K+8V+2RQ-8VQ3,7RF%<?-][M
MW[T^2PL/+\_[#;>8J[@WDKD'9NST]0#^%%% $K:;IL2OY>GVJ^5NF3$*_*_]
MX<<'WJ!=/T_G_0+;YBC']RO)^]GIZDG\:** $73[!G^:PMCM\K'[E>-WWNW?
MOZU*EG9VT!N;:SMX9E1\/'$JD?D/8?E110!%]BLD#LEC;*8O+D0B%1M9C\Q'
M'!/?UJ4:?I_DJGV"VVKA0/)7@.VUAT[C@^M%% $8TS3?.,/]G6OE_-\ODKCE
M?I[#\JY3Q!I]C)XBTZ%K.'9-):[L( 5+O-O92.48X&67!X'/%%% T=[+I]C<
M2+/<6<,TJK@-(@8@?C6>UM:Y9OLD&61)B?*7E\_>Z=:**!'-^++:UM?$'@^&
MVL[>*.;5PLBK"H##[/+P>/<_G70Q6%A/!)--86TDC_>9H5)/R?3V'Y444 5?
A)A7QU:VJ1(D*6$EPJ(H4"1I%#/QW()&?<^IKJ*** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>cosm_ex991img2.jpg
<TEXT>
begin 644 cosm_ex991img2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" !; * # 2(  A$! Q$!_\0
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MQ@H\NDH7?<S_ (E_ O1_ O@:Z\26>O7U[+!+%&(IHXPI#N%)) SWKV?X _\
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7 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139647229328448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jul. 19, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Cosmos Holdings Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001474167<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 19,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">27-0611758<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-54436<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address Address Line 1</a></td>
<td class="text">141 West Jackson Blvd, Suite 4236<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address City Or Town</a></td>
<td class="text">Chicago<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address State Or Province</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address Postal Zip Code</a></td>
<td class="text">60604<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">312<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">865-0026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">COSM<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $.001<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>cosm_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cosm-20220719.xsd" xlink:type="simple"/>
    <context id="From2022-07-19to2022-07-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001474167</identifier>
        </entity>
        <period>
            <startDate>2022-07-19</startDate>
            <endDate>2022-07-19</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-07-19to2022-07-19">0001474167</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-07-19to2022-07-19">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2022-07-19to2022-07-19">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-07-19to2022-07-19">2022-07-19</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-07-19to2022-07-19">Cosmos Holdings Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-07-19to2022-07-19">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-07-19to2022-07-19">000-54436</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-07-19to2022-07-19">27-0611758</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-07-19to2022-07-19">141 West Jackson Blvd, Suite 4236</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2022-07-19to2022-07-19">Chicago</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-07-19to2022-07-19">IL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-07-19to2022-07-19">60604</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-07-19to2022-07-19">312</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-07-19to2022-07-19">865-0026</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="From2022-07-19to2022-07-19">Common Stock, par value $.001</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-07-19to2022-07-19">COSM</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-07-19to2022-07-19">NASDAQ</dei:SecurityExchangeName>
    <dei:WrittenCommunications contextRef="From2022-07-19to2022-07-19">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-07-19to2022-07-19">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-07-19to2022-07-19">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-07-19to2022-07-19">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-07-19to2022-07-19">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M 0  (@(   \   !X;"]W;W)K8F]O:RYX;6R-4=%NPC ,_)4J'[ 6M"$-45Y
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MX_T,:3?D@6)8YL_X>\87_QO.\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0
M   ( %8P^50'04UB@0   +$    0              "  0    !D;V-0<F]P
M<R]A<' N>&UL4$L! A0#%     @ 5C#Y5)&.A-'O    *P(  !$
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M;',O+G)E;'-02P$"% ,4    " !6,/E4JL0B%C,!   B @  #P
M    @ %&$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ 5C#Y5"0>FZ*M
M    ^ $  !H              ( !IA$  'AL+U]R96QS+W=O<FMB;V]K+GAM
M;"YR96QS4$L! A0#%     @ 5C#Y5&60>9(9 0  SP,  !,
M ( !BQ(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  U1,
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="cosm_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cosm.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="cosm_8k.htm">cosm_8k.htm</File>
    <File>cosm-20220719.xsd</File>
    <File>cosm-20220719_cal.xml</File>
    <File>cosm-20220719_def.xml</File>
    <File>cosm-20220719_lab.xml</File>
    <File>cosm-20220719_pre.xml</File>
    <File>cosm_ex101.htm</File>
    <File>cosm_ex991.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cosm_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "calculationLink": {
     "local": [
      "cosm-20220719_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cosm-20220719_def.xml"
     ]
    },
    "inline": {
     "local": [
      "cosm_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cosm-20220719_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cosm-20220719_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cosm-20220719.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "cosm",
   "nsuri": "http://cosm.com/20220719",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "strong",
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cosm_8k.htm",
      "contextRef": "From2022-07-19to2022-07-19",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000001 - Document - Cover",
     "role": "http://cosm.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "strong",
       "span",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "baseRef": "cosm_8k.htm",
      "contextRef": "From2022-07-19to2022-07-19",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address Address Line 1"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address City Or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address State Or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://cosm.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001477932-22-005336-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001477932-22-005336-xbrl.zip
M4$L#!!0    ( %8P^51 \+Q:A@0  (,6   1    8V]S;2TR,#(R,#<Q.2YX
M<V3-6%MOVS84?A^P_\#J91M029:-IK/AI,BE!0*D&>!T0]X&FJ9M8C*ID90O
M_[Z'U-V67$G.0_-$^GS?N>N0S/33?A.B+96*"7[M!-[ 0903L6!\=>W$RL6*
M,.8@I3%?X%!P>NT<J'(^W?SZR_2=Z[[>S9[0@R#QAG*-[B7%FB[0CNDU,J*O
M6&DJ73=%_Y/8F:"A-_(&?^:_WV$%+,$M!X1!+GD ?4@L$3&:+77PT1^._.%@
M.,Q!+V*I=UA2A"59,TV)CB4.T8(JMN(('$=)0!-T^QM!#VLL-SB2=(.Y"0K=
M;K67Z[H7T4&RU5JCW\D?R)A!C^[SYV_H+E:,4Z70BPACXXIZCQXY\=!M&**9
M82@THXK*+5VDZA19@Q$$&>9JL@^OG;76T<3W=[N=MY_+T!-R!9$,1O[K$^/_
M.2E2TF4C],H':08DL910K$..MDA%B;<26S^3VEQE%*CH"N/(Q5KGK"56<ZL_
M%?H@E&P>:ZAS2E.,U!L!044_W9-U/=)(*E#&MU3I>G B W@P<@>!.PHR$J<K
MTV&-^1G[4H343V$Y"S.BZBU9T7&*]"&BJC8_5E*!*QW)AMR I RM.+T;92X'
M_NO7IQ?;*D[>*] .=?!@/![[5II!3Y#5QC+B.7Q=N6:0LC-XQLV73BKXQ5&1
M4O '/Q%6H*P6>I5 6=ZX(N9:-O5M(JS61,LS)0=I7@VIFZJ7BRJ:%UH>$2KZ
M0>P;L>$,3"L.@[(ITVP-IJRH:HJR^HA!4 'R>/,#;P!!)2,Y0? 6','=(Q[X
M6>M\W<AH'A=E,!&J\,-L/"(V%C'X&(P=E(^6+T)N'N@2QR&X$//_8QRR)3.?
M+ VI.4PJ@))88[FB^AEOJ(HPH6>,P0A&4\RYT/;H,%O81Q'C2V$W:&H^CXFI
MU#?($#*+OV>/IRKM3+D7<$PZB,'P29:)CE3)@BX99];.P/P%R"W.11=9QM0_
MAI8UQ' &_L5O[!I.)P5$Z[<Y&E)F"FEB$1R2..Q(*KQIX*0_95DJ9RZ;+C.Z
M1'8J34RG73N*;:+0S!#[V]H>:":9;E:;?R% #SHF@QCE9Z:2S?]Q3E+#F0HX
M^T^TG$Q-4"(B*C6#3[,8C?[;Q!3B>=>8@$+#GS(8Z*6NP1RUWT\7$G1ZUY"J
M'\=;1S3U2],(-I51-85XA-2(GTRZ<Z=V<N5\$L3J.4,Q.S?CN>8G-QC"1<O;
MJT7J7Q</BM"Z>9#QNGI0?Q%I:3LC&*,?VINKOZ#4V53G*-G&-F8/Z]5K?3OS
M94Z^Z^E <5MI93N#FT5[BRVN,&V*768^)T13]+'IM.#J$D_Z>='/A:9W5*O\
MYWB[ZED!>\U.YQU< (EVZ3X*X?VLA3Q\@7V[1(125K1\+I1<5)::AU];=\JL
M-_.A0SHRQD4]47[$MFJ*@I L>XZ"XO7?RFH&-XOV%AM?56=MGCQG?!IJ5>CH
M:;_\@.QKW^JX=!26WZ--COR(:?>J1]F+?VRTJWN&MZL>F8>79O?"EY^G2?(S
M-?T\Z%[Z6@\Z5K_F6=ZW[WI%77KA7Q"T_9]CU?[43_3=? =02P,$%     @
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MO?+8L]^52ON]"R$NZ6;T:C]NGP%02P,$%     @ 5C#Y5'YNB?F1 @  1 @
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MG%;95W/7$G;!9[0N>J@5 QN3332/[^$5#O B(MR1!D;"(Y)U22]+-S9/_.
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M-&__*VK>2,+_/:<'@:C60TBX[5.8)YI!<6K%RN,,#\>RHQB1*@:%P[!K$5>
MHQ$\G:=;13C#!4.8 !>,=#_X$R6S,E);+O),NH?XL*O+$>ZB&USU>CB95W_
MN@KQB=2)<>2-<8FUBT+>7=TC;+&8[;'""6G3 ](B(Q<EV<'>8YO!YY0FQ2C?
M2)Q8MCRP++3BX=I_R$ EN,'Y7<FEF79E-J.B<@4H"7 "_<[;.E!IT\MJ, #%
M9?P@8KM/K5X6WDB=4+_WN#X46O,PMW&/+=5,JIS-"R*"KISC_6#=E7'E1N),
MH-, _.9MKCO9]C <([KJQ6B03_BF:'B:9^/7;7'10)2&. W!E;<A.&/UHO#_
M5MQ@H8)K7C87VW1T,?02J1/L#QY@5UJ[*&2L[#GC!N\PCWB]*4[38L)%.B>\
MUQ[PEINZ*-N! CO"(!CDNT];=*OGR:1LZ:C2NY4K/FK"\RY]0N]I/0?U7]$7
M1+D-@(^"T=6QASOG9Y["^9OEH<H-LX\BLLR1!ZR=.$8P>OO6YP*B*KZ%<C?0
M/BK,LQ[]$>_BQV<UDDOAP/M0[$;;7YE9ZL\?Z[P >%8#)1=\\UC@'/"3"#?J
M/BI.%Z?^T ^D-C3]A\_.U9O%>C?L_NK,*I<7A6XOMXX"6H[Y6.$&UD?U6.3D
MHBCM\[QT,)6B<K]QJG)#ZJ-&+'-T4:PC1>U3Y)=U-I8EE>$;B1M0'U5AH9?+
M%MO YLK^4W?%IE0D4/Y<L%CI]H#%1Q%8Y<P+XJ@Y'MG'U=5X7U5N:'V4=V6.
M3K#>A">YX[;YF_U5QN:,?;&_5/CX+U!+ P04    " !6,/E411S!^#D7  #/
M@P  "P   &-O<VU?.&LN:'1M[3UK<R*WLG]%UTG.VE6\P2_L]2D68X?$#\IX
MD]Q\N25F!"@>1A-IQC;GUY]N23/,\+#!,7C7UZE*K4&O5K^[U1+'_WX<>>2>
M2<6%_WFK7"AM$>8[PN7^X/-6%/;S!UO_/CD>AM +>OJJSA\_;PW#,*@7BP\/
M#X7'GO0*0@Z*E5*Y6N2^QWWVQY>;BZVD>SB__Z1K,9345WTA1S0$*'"FW7RI
MDJ_LI2;)*^9D)H+/A8&X?W:>@WRU',_C1%+"[L;)1!J:>*:X%096*G9(9LF'
MJH:\?'AX6'Q$E,3S/BH^KV.E5"H7_[B\Z#I#-J)Y[JN0^@Y+1@'@=XL7P-:X
MZTS/%-I+U2(V]ZB:S RM_(G^,Y! JQMFL6([[Q9-8Z8KG]MUSW3E<5>7\?F(
MAH8TCNM^-)H/K!O*8C@.6!%Z,,F=9(#PEQ@C_/S4.,GZ"[&R5X36A.&4J%7*
M^T^AT/2(!T0J+X7')OS2IZJG>\<MF1T[(O)#N8@/36-F0!3*A< <%J$U[JAD
MF,?MSX$D:<K,#/B:&C ?G3"FE"^5\Y5R:JFYBV0!5_D!I<%<O&##%%K4A*KX
MH>"(D>Y1VB\?;H$>8M0].0YYZ+$3;/^_@[L"".)QT7QU_#_Y_*EP@.A^2)J2
MT9"YI#<FJ!TNJ0J9S.=/CD<LI 07R;._(W[_>:LI_!!&Y&]AGUO$,9\^;X7L
M,2P:,2^>'!?-VCWACHD*QQXS'?+4XP.__E>D0MX?'_5A<+U<"D(2\A%3Q&</
M1(H1]0%XE]_;D9]<K@*/CI&1V=$JTQR-J!QP/^^Q?EC?_RG^*/E@J#]_(MS]
M_ GW>]K^[=/),7^L(]Q,FC^YZS)?_PDK7QGA(#X=P69 *.LM'_ X;L+N)?7:
MOLL>?V5CBY''\ :EYPS 0(+D2_OY\F$H)G]OG91 W]7V:^6]_>-B9HG%*S:
M5"Z2Z\RC@Z57(D;)?]X"PU#O"1 OZO>I!PKP1/\SLWPQNWF0=(:JGJF38]2=
M=:4U-"Q+M-JM(\=__J3X*/#8)_O=$+7')^2Z?,R1A4?E I*+V3G,<NDU]$<E
M(JD_:>U<MUM%>CV)5-N=:=+$G[B+G_N<2:*797--8[/]:Y8HTX-/XJ^RLP>
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M]A=P+13S<^02&.=.P_@;I[ _& !]'\!0Z4MVPISU&N:4 RSI/</"FTLL3QV
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MQ/D(P+[; *PV'8"M,0PJVIGQA^I/_@M02P,$%     @ 5C#Y5"(7T4'8&@
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MY#F\*C5\<$-9%[R6>:=%9@O'.VUF4Y-=ZA@HLC$*'5MJU2]<*U4E_&(M2Q.
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M4$L! A0#%     @ 5C#Y5$4<P?@Y%P  SX,   L              ( !>A0
M &-O<VU?.&LN:'1M4$L! A0#%     @ 5C#Y5"(7T4'8&@  C[8   X
M         ( !W"L  &-O<VU?97@Q,#$N:'1M4$L! A0#%     @ 5C#Y5*^1
M*QI2#@  @S    X              ( !X$8  &-O<VU?97@Y.3$N:'1M4$L%
3!@     (  @ _ $  %Y5      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
